| Document |
Document Title |
|
WO/2009/094867A1 |
The present invention relates to a the heterocyclic or splitring nitrogenous compounds of formula (A), where R1-R5, Y, Z and W are as defined in the specification. The present invention discloses the preparation and the uses of an insect...
|
|
WO/2009/078036A2 |
The present invention relates to a process for the preparation of Letrozole involving the use of novel intermediate of Formula I.
|
|
WO/2009/068509A1 |
This invention relates to novel benzamide derivatives that are found to be potent modulators of potassium channels and, as such, are valuable candidates for the treatment of diseases or disorders as diverse as those which are responsive ...
|
|
WO/2009/064031A1 |
There is provided a compound having an excellent controlling effect on pests, represented by the formula (I): wherein, A and E independently represent a -R1 group, a -L1-R1 group, etc.; G represents a -L2-R1 group, a -S(O)2-R4 group, etc...
|
|
WO/2009/053250A1 |
The invention relates to compounds of the formula (I), in which the substituents have the meanings given in the description, method for producing said compounds, agents comprising the same, and the use thereof to combat damaging fungi.
|
|
WO/2009/014267A2 |
There is provided a compound having an excellent controlling effect on arthropod pests represented by the formula (I-1): wherein Z represents an optionally substituted carbocyclic group or an optionally substituted heterocyclic group; G ...
|
|
WO/2009/006243A2 |
The invention relates to processes for the preparation of the bicyclic oxazine carboxaldehyde Compound 1: (I) The invention also relates to the use of Compound 1 in the preparation of β-lactamase inhibitors.
|
|
WO/2008/145609A1 |
The present invention refers to novel agents for covalently conjugating His-tagged proteins, to covalent conjugates of His-tagged proteins and to methods of making such conjugates.
|
|
WO/2008/133169A1 |
Disclosed is a method for producing an N-(2-amino-1,2-dicyanovinyl)imidate represented by the formula (1-III) at a lower reaction temperature, within a short time, and in high yield. Also disclosed is a method for producing an N-(2-amino...
|
|
WO/2008/110313A1 |
The invention relates to phenoxyphenylamidines of general formula (I), a method for production thereof and use of said amidines for preventing undesired microorganisms and an agent for said purpose, comprising said phenoxyphenylamidines....
|
|
WO/2008/110281A2 |
The jinvention relates to 3,4-disubstituted phenoxyphenylamidines of geenral formula (I), a method for production thereof, and use of said amidines for preventing undesired microorganisms and an agent for said purpose, comprising said ph...
|
|
WO/2008/110280A2 |
The invention relates to 3-substituted phenoxyphenylamidines of general formula (I), a method for production thereof and use of said amidines for preventing undesired microorganisms and an agent for said purpose, comprising said phenoxya...
|
|
WO/2008/110312A1 |
The present invention relates to oximether-, hydrazone-, or azomethine-substituted phenylamidines having the general formula (I), a method for the production thereof, the use of the claimed amidines for combating unwanted microorganisms,...
|
|
WO/2008/110278A2 |
The use of N2-phenylamidines of general formula (I) as herbicides is disclosed. In said general formula (I) R2, R3, R4, R5 and R6 are various groups and A is a bond or various single- or multi-atom bridge elements.
|
|
WO/2008/110314A1 |
The invention relates to fluoroalkylphenylamidines of general formula (I), a method for production thereof and use of said amidines for preventing undesired microorganisms and an agent for said purpose, comprising said phenoxyamidines. T...
|
|
WO/2008/110315A1 |
The invention relates to 4-cycloallkyl or 4-aryl substituted phenoxyphenylamidines of general formula (I), a method for production thereof and use of said amidines for preventing undesired microorganisms and an agent for said purpose, co...
|
|
WO/2008/110279A1 |
The invention relates to dihalophenoxyphenylamidines of general formula (I), a method for production thereof, the use of said amidines to prevent undesired microorganisms, and an agent for said purpose comprising said phenoxyamidines. Th...
|
|
WO/2008/107176A1 |
The invention relates to meta-substituted phenyl sulfonyl amides of secondary amino acid amides according to the general formula (I), (II), or (III), the production thereof, and the use thereof as matriptase inhibitors, in particular the...
|
|
WO/2008/031508A1 |
The invention relates to the compounds of formula (I) having antithrombotic activity which especially inhibit blood coagulation factor IXa, to methods for producing the same and to the use thereof as drugs.
|
|
WO/2008/015133A2 |
The present invention relates to a novel process for preparing amidrazones of the formula (I) wherein R, R1, R2, A, B, W, Y and n have the meanings as indicated in the description. Further, the invention relates to novel compounds used a...
|
|
WO/2008/008316A2 |
The invention provides a compound and, tautomeric forms thereof having the formula (I): wherein Rf 1 is selected from the group consisting of hydrogen, a straight chain, branched secondary or branched tertiary C1-C20 perfluoroalkyl group...
|
|
WO/2008/002546A1 |
Metal(IV) tetrakis(N,N'-dialkylamidinates) were synthesized and characterized. Exemplary metals include hafnium, zirconium, tantalum, niobium, tungsten, molybdenum, tin and uranium. These compounds are volatile, highly stable thermally, ...
|
|
WO/2007/141662A2 |
An amidine-carboxylic acid complex in accordance with an aspect of the invention has an amidine ligand and a carboxylic acid ligand that are coordinated to one metal atom or a plurality of metal atoms of the same element. A multiple-comp...
|
|
WO/2007/126857A1 |
The instant invention is directed towards compounds, including diamidines, that inhibit Tdpl and are useful in the treatment and/or prevention of cancer and parasitic disease.
|
|
WO/2007/113644A2 |
The present invention relates to novel compounds of the general formula (I), having histone deacetylase (HDAC) inhibiting enzymatic activity, their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, ph...
|
|
WO/2007/093227A1 |
The present invention relates to 2,5-di-substituted-4-naphthyloxy-substituted-phenyl-amidine derivatives of formula (I) wherein the substituents are as in the description, their process of preparation, their use as fungicide or insectici...
|
|
WO/2007/090617A2 |
This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an α-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis,...
|
|
WO/2007/074789A1 |
Disclosed is a novel process intermediate represented by the general formula (1) or (2): wherein X represents a halogen atom, a cyano group or the like; Y represents a halogen atom, a cyano group or the like; R1 represents a C1-C6 haloal...
|
|
WO/2007/061966A2 |
Compounds of Formula 1, and their N-oxides and agriculturally suitable salts, are disclosed as useful as fungicides (Formula 1) here wherein R1 is C1-C4 alkyl or C3-C4 cycloalkyl; R2 is C1-C3 alkyl; R3 is Br, Cl or I; R4 is Cl; or C1-C2 ...
|
|
WO/2007/056469A2 |
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.
|
|
WO/2007/051756A1 |
The present invention relates to a novel crystalline modification of N-ethyl-2,2-dichloro-1-methylcyclopropane-carboxamide-2-(2,6
-dichloro- α,α,α -trifluoro-p-tolyl)hydrazone, to a process for its preparation and to its use for comba...
|
|
WO/2007/043568A1 |
A drug, specifically, a novel arylamidrazone derivative having an antagonistic effect on an S1P3 receptor; and a medicine containing the drug as an active ingredient. The drug is an arylamidrazone derivative represented by the following ...
|
|
WO/2007/035143A1 |
A composition is provided, which comprises a serine protease; a reversible inhibitor of said serine protease; and a stabilizing agent M having the formula (I): Also provided are uses of the composition as a medicament, and other uses and...
|
|
WO/2007/031512A2 |
The present invention relates to bi-phenyl-amidine derivatives of formula (I) in which the substituents are as in the description, their process of preparation, their use as fungicide or insecticide active agents, particularly in the for...
|
|
WO/2007/031526A1 |
The present invention relates to benzyloxy- and phenethyl-substituted phenyl-amidine derivatives of formula (I) wherein the substituents are as in the description, their process of preparation, their use as fungicide or insecticide activ...
|
|
WO/2007/031508A1 |
The present invention relates to 2,5-di-substituted-4-phenyloxy-substituted-phenyl-amidine derivatives of formula (I) in which the substituents are as in the description, their process of preparation, their use as fungicide or insecticid...
|
|
WO/2007/033266A2 |
Pharmaceutical compositions comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-
dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and pharmaceutically acceptable salts thereof are provided as well as kits and articles of m...
|
|
WO/2007/017687A2 |
A compound of formula (III): or a salt, solvate and chemically protected form thereof, wherein: R5 is an optionally substituted C5-20 aryl or C4-20 alkyl group; L' is a single bond, -O- or -C(=O)-; A is selected from the group consisting...
|
|
WO/2007/015436A1 |
A compound which has thermal stability and moderate vaporizability and is satisfactory as a material for the CVD or ALD method; a process for producing the compound; a thin film formed from the compound as a raw material; and a method of...
|
|
WO/2006/121391A1 |
A compound of formula (I), or pharmaceutically acceptable salts thereof wherein X is selected from hydrogen, halo, -CN, -CON2, -CON(C1-6alkyl)H, -CON(C1-6alkyl)2 and heterocyclic groups; R1 is selected from C1-6alkyl and C3-6cycloalkyl; ...
|
|
WO/2006/091669A1 |
Disclosed herein are various novel oxazolidinone, imidazolidinone, and thiazolidinone analogs and methods of treating cancer and/or microbial infection using these analogs. Particular 4-oxazolidinone compounds are shown to have anti-canc...
|
|
WO/2006/084031A1 |
The present invention provides a class of chemical compounds useful in the treatment of sickle cell disease, diseases characterized by unwanted or abnormal cell proliferation and for the treatment of ocular disorders such as glaucoma. Th...
|
|
WO/2006/083003A1 |
A novel compound, or a pharmaceutically acceptable salt thereof, represented by the formula (1) wherein the characters are as defined in the description. Thus, there can be provided an activated blood coagulation factor X inhibitor and a...
|
|
WO/2006/077854A1 |
A method for producing an imide ether compound in high yield is provided. The method is characterized in that a nitrile compound, an alcohol and a hydrogen halide are continuously introduced into a flow reaction apparatus comprising a mi...
|
|
WO/2006/070878A1 |
It is intended to provide a compound which has an anticoagulant effect based on the inhibition of the activated blood coagulation factor VII and, therefore, is useful as a blood coagulation inhibitor or a preventive/remedy for diseases c...
|
|
WO/2006/064757A1 |
A compound represented by the general formula (I), a salt thereof, an N-oxide form thereof, a solvate thereof, or a prodrug of any of these; and a drug containing any of these. (I) (In the formula, all the symbols are as defined in the d...
|
|
WO/2006/041119A1 |
Compounds represented by the general formula (1) or salts thereof, or hydrates of both, which are safe and have moderate physicochemical stability and which are useful as preventive or therapeutic agents for diseases caused by thrombus f...
|
|
WO/2006/031556A2 |
The invention provides novel ß2 adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with ß2adrenergic re...
|
|
WO/2006/027135A1 |
The invention is concerned with novel 4-aminomethyl benzamidine derivatives of formula (I) wherein Ar and X are as defined in the description and in the claims, as well as prodrugs and pharmaceutically acceptable salts thereof. These com...
|
|
WO/2006/021833A2 |
A method of combating infectious agents, such as Pneumocystis pneumonia, and a method of treating a subject in need of such treatment is disclosed. The method comprises administering to the subject a bis-benzamidoxime of formula (I) wher...
|
